▶주메뉴 바로가기

▶본문 바로가기

THE INVESTOR
November 15, 2018
Big Reunion

Market Now

CKD Bio to invest W28.5b in facilities

  • PUBLISHED :September 14, 2018 - 14:22
  • UPDATED :September 14, 2018 - 14:22
  • 폰트작게
  • 폰트크게
  • facebook
  • twitter
  • sms
  • print
[DISCLOSURE] Chongkundang Bio (063160) said on Sept. 14 that it has decided to invest 28.5 billion won (US$25.48 million) in new facilities for probiotics to increase manufacturing capacity and to build fill and finish facilities. It will also build microbiome facilities. 

This amounts to 20.04 percent of its equity capital and the investment period is until Nov. 30, 2019.

By Hwang You-mee (glamazon@heraldcorp.com)

  • facebook
  • twitter
  • sms
  • print

EDITOR'S PICKS